Corbus Pharmaceuticals Holdings Inc CRBP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/19/22 EDT
0.22quote price arrow up+0.00 (+0.42%)
Volume
38,931
Close
0.2142quote price arrow down-0.0073 (-3.2957%)
Volume
1,127,793
52 week range
0.21 - 1.32
Loading...
  • Open0.2317
  • Day High0.2317
  • Day Low0.21
  • Prev Close0.2215
  • 52 Week High1.32
  • 52 Week High Date09/03/21
  • 52 Week Low0.21
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap26.83M
  • Shares Out125.27M
  • 10 Day Average Volume2.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.92
  • YTD % Change-65.21

KEY STATS

  • Open0.2317
  • Day High0.2317
  • Day Low0.21
  • Prev Close0.2215
  • 52 Week High1.32
  • 52 Week High Date09/03/21
  • 52 Week Low0.21
  • 52 Week Low Date05/12/22
  • Market Cap26.83M
  • Shares Out125.27M
  • 10 Day Average Volume2.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.92
  • YTD % Change-65.21

RATIOS/PROFITABILITY

  • EPS (TTM)-0.28
  • P/E (TTM)-0.76
  • Fwd P/E (NTM)-0.89
  • EBITDA (TTM)-38.273M
  • ROE (TTM)-55.56%
  • Revenue (TTM)100,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-36,090.23%
  • Debt To Equity (MRQ)38.81%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corbus Pharmaceuticals Holdings Inc

There is no recent news for this security.

Profile

MORE
Corbus Pharmaceuticals Holdings, Inc. is focused on the development of immune modulators that have application in disease states spanning from immuno-oncology to fibrosis. The Company’s pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. The Company pipeline includes Anti-integrin monoclonal antibodies (mAbs), Cannabinoid receptor type 1 (CB1) and Lenabasum. The mAbs is...
Alan Holmer J.D.
Independent Chairman of the Board
Yuval Cohen
Chief Executive Officer, Director
Craig Millian
Chief Operating Officer
Sean Moran CPA
Chief Financial Officer
Address
500 River Ridge Drive
Norwood, MA
02062
United States

Top Peers

SYMBOLLASTCHG%CHG
OTLC
Oncotelic Therapeutics Inc
0.0855-0.0045-5.00%
NNVC
NanoViricides Inc
2.43-0.06-2.41%
CLBS
Caladrius Biosciences Inc
0.5313+0.0095+1.82%
VINC
Vincerx Pharma Inc
1.65-0.07-4.07%
ELEV
Elevation Oncology Inc
1.26-0.01-0.79%